These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1665684)

  • 1. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.
    Gitsch G; Kohlberger P; Hanzal E; Kölbl H; Breitenecker G
    Arch Gynecol Obstet; 1991; 249(4):173-7. PubMed ID: 1665684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas.
    Gitsch G; Kohlberger P; Steiner A; Neumeister B; Breitenecker G
    Arch Gynecol Obstet; 1992; 251(4):193-7. PubMed ID: 1380231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical differentiation of granulosa cell tumors and undifferentiated ovarian cancers].
    Kohlberger P
    Wien Klin Wochenschr; 1993; 105(20):589-90. PubMed ID: 8259687
    [No Abstract]   [Full Text] [Related]  

  • 4. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
    Aguirre P; Thor AD; Scully RE
    Am J Clin Pathol; 1989 Aug; 92(2):140-9. PubMed ID: 2474244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical differentiation of granulosa cell tumors and ovarian cancers].
    Gitsch G; Kohlberger P; Kölbl H; Krepler R; Breitenecker G
    Gynakol Rundsch; 1991; 31 Suppl 2():370-2. PubMed ID: 1790983
    [No Abstract]   [Full Text] [Related]  

  • 8. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.
    van Niekerk CC; Boerman OC; Ramaekers FC; Poels LG
    Am J Pathol; 1991 Feb; 138(2):455-63. PubMed ID: 1992770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the capillary vascular pattern in ovarian tumors.
    Omar AH; el-Kateb H; Fathalla MF
    Am J Obstet Gynecol; 1971 Sep; 111(2):200-4. PubMed ID: 4329137
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.
    Chadha S; van der Kwast TH
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(5):439-45. PubMed ID: 2471350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composite mucinous and granulosa-cell tumor of ovary: case report of a unique neoplasm.
    Price A; Russell P; Elliott P; Bannatyne P
    Int J Gynecol Pathol; 1990; 9(4):372-8. PubMed ID: 2174027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1203-14. PubMed ID: 9777982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of inhibin in the identification of granulosa cell tumors of the ovary.
    Hildebrandt RH; Rouse RV; Longacre TA
    Hum Pathol; 1997 Dec; 28(12):1387-95. PubMed ID: 9416696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic parameters in patients with advanced ovarian malignant tumors.
    Pohl R; Dallenbach-Hellweg G; Plügge T; Czernobilsky B
    Eur J Gynaecol Oncol; 1984; 5(3):160-9. PubMed ID: 6329760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential diagnosis of primary peritoneal papillary tumors.
    Gitsch G; Tabery U; Feigl W; Breitenecker G
    Arch Gynecol Obstet; 1992; 251(3):139-44. PubMed ID: 1376598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous occurrence of a granulosa cell tumour and a serous papillary cystadenocarcinoma in the same ovary. A case report.
    Bichel P
    Acta Pathol Microbiol Immunol Scand A; 1985 Jul; 93(4):175-81. PubMed ID: 4036607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.